seroquel class action lawsuit
Contact Information

Greg Monforton and Partners

100 Ouellette Avenue
13th Floor
Windsor, Ontario N9A 6T3

519-258-6490
800-663-1145

serevent lawyers canada
Serevent Lawsuit Current Consumer Cases
Canada Lawyers Represent people Injured by Serevent Asthma Inhalers

June 8, 2006—Researchers conducting a study assessing the safety of Serevent found that the inhaler more than tripled the risk of asthma-related deaths and concluded Serevent and Advair, a similar asthma drug, should not be used. In addition to the added risk of death, researchers found those using Serevent also were at a greater risk for hospitalization from life-threatening side effects.

Our lawyers want to help if you have been injured or lost a loved one as a result of Serevent. Because the law limits the amount of time a person has to file a lawsuit for injuries caused by defective pharmaceuticals like Serevent, you should contact us immediately.

FDA Committee Recommends Stronger Serevent Warning Contact Form
serevent inhaler warning side effects

July 30, 2005—The FDA's Pulmonary-Allergy Drugs Advisory Committee voted to recommend stronger warnings for Serevent. This decision came six months after a clinical study was stopped prematurely after data revealed serious side effects associated with Serevent.

This announcement came approximately one year after the FDA announced it would require GlaxoSmithKline to include more stringent warnings relating to potentially life-threatening side effects of Serevent. A similar warning also was added to GSK's Advair, another asthma inhaler.

Name
Phone
Email
 

Clinical Study Alerts Researchers to Problems With Serevent Serevent News

A clinical trial undertaken to assess the safety of Serevent produced alarming results. The study demonstrated that Serevent users were more likely to suffer life-threatening asthma attacks. Fifty patients out of 13,176 given Serevent either died or suffered a life-threatening asthma attack during the course of the clinical trial.

Dr. David Graham, associate science director of the FDA Office of Drug Safety, testified before the U.S. Congress that Serevent poses a significant health risk and urged more stringent action be taken to protect patients. Dr. Graham believed the August 2004 warnings issued by the FDA did not go far enough to protect those taking the drug.

Common Asthma Inhalers Cause up to 80 Percent of Asthma-Related Deaths
Chronicle Online
June 9, 2006

Study Fuels Debate Over Serevent and Advair
CBC News
June 8, 2006

FDA Adds Warnings to Serevent
MSNBC
August 9, 2004
SEREVENT Lawyers Serevent black Box Warning

Our law firm has compiled important information on the latest development of the asthma drug Serevent. We encourage you to visit the Serevent news page for more details on the Serevent warning on recent lawsuits.

Greg Monforton and Partners is handling legal claims against GlaxoSmithKline on behalf of Canadians injured by the drug Serevent.

If you or a loved one has been seriously injured as a result of Serevent, we encourage you to contact us. We will represent clients throughout Canada in lawsuits against GlaxoSmithKline.

For more information about the Serevent lawsuit, please complete our online form.

Data from a large placebo-controlled US study that compared the safety of salmeterol (SEREVENT Inhalation Aerosol) or placebo added to usual asthma therap showed a small but significant increase in asthma-related deaths in patients receiving salmeterol (13 deaths out of 13,176 patients treated for 28 weeks) versus those on placebo (3 of 13,179).